news
Plasticell, a developer of stem cell technologies and cell-based therapies,…
31 March 2017 | By Niamh Marriott (Drug Target Review)
Plasticell, a developer of stem cell technologies and cell-based therapies, has signed agreements with the Agency for Science, Technology and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stem cell pipeline.